Hikal gets nod to raise Rs 375 crore through NCDs

14 Feb 2022 Evaluate

Hikal has received approval to raise Rs 375 crore through 3750 Unrated, unlisted, secured, redeemable, Non-Convertible Debentures (NCDs) on private placement basis. Date of maturity will be 8 years from the date of allotment. The Board of Directors of the Company at its meeting held on February 14, 2022, has approved the same.

Hikal is a leading manufacturer and supplier of API's and intermediates globally.

Hikal Share Price

383.85 3.50 (0.92%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.